|
Status |
Public on Jan 17, 2013 |
Title |
CBFb Stabilizes HIV Vif to Counteract APOBEC3 at the Expense of RUNX1 Target Gene Expression [ChIP-seq] |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
The HIV-1 accessory protein Vif hijacks a cellular Cullin-RING ubiquitin ligase, CRL5, to promote degradation of the APOBEC3 (A3) family of restriction factors. Recently, the cellular transcription cofactor CBFb was shown to form a complex with CRL5-Vif and to be essential for A3 degradation and viral infectivity. We now demonstrate that CBFb is required for assembling a well-ordered CRL5-Vif complex by inhibiting Vif oligomerization and by activating CRL5-Vif via direct interaction. The CRL5-Vif-CBFb holoenzyme forms a welldefined heterohexamer, indicating that Vif simultaneously hijacks CRL5 and CBFb. Heterodimers of CBFb and RUNX transcription factors contribute toward the regulation of genes, including those with immune system functions. We show that binding of Vif to CBFb is mutually exclusive with RUNX heterodimerization and impacts the expression of genes whose regulatory domains are associated with RUNX1. Our results provide a mechanism by which a pathogen with limited coding capacity uses one factor to hijack multiple host pathways.
|
|
|
Overall design |
Identification of RUNX1 binding sites in the Jurkat cell line
|
|
|
Contributor(s) |
Hartley PD, Krogan NJ |
Citation(s) |
23333304 |
Submission date |
Nov 28, 2012 |
Last update date |
May 15, 2019 |
Contact name |
Nevan Krogan |
E-mail(s) |
nevan.krogan@ucsf.edu
|
Phone |
415-476-2980
|
Fax |
415-514-9736
|
Organization name |
University of California, San Francisco
|
Department |
Cellular & Molecular Pharmacology
|
Lab |
Krogan
|
Street address |
1700 4th Street
|
City |
San Francisco |
ZIP/Postal code |
94158 |
Country |
USA |
|
|
Platforms (1) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
Samples (2) |
|
This SubSeries is part of SuperSeries: |
GSE42576 |
CBFb Stabilizes HIV Vif to Counteract APOBEC3 at the Expense of RUNX1 Target Gene Expression |
|
Relations |
BioProject |
PRJNA182318 |
SRA |
SRP017335 |